Clinical Trials Browser

Phase 2 × UNKNOWN × Thyroid Neoplasms × Clear all

NCT03199677 2017-07-02

A Clinical Study of Apatinib in Patients With Local Progressive/Metastatic Refractory Thyroid Cancer

Phase 2 Unknown

Neoplasms, Thyroid Neoplasms